Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Cazzolato

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Pharmacological Research|May 1, 1994
Probucol protects low-density lipoproteins from in vitro and in vivo oxidationG Bittolo-Bon, G Cazzolato, P Avogaro
Arteriosclerosis (Dallas, Tex.)|January 1, 1985
Apoprotein B-48 is a constant finding in very low density lipoproteins of humansG Cazzolato, G Bittolo Bon, P Avogaro
Atherosclerosis|February 1, 1988
A question concerning apo B-48P Avogaro, G Cazzolato, G Bittolo Bon
Arteriosclerosis (Dallas, Tex.)|January 1, 1988
Presence of a modified low density lipoprotein in humansP Avogaro, G B Bon, G Cazzolato
Advances in Experimental Medicine and Biology|January 1, 1987
Meaning of a modified LDL in humansP Avogaro, G Bittolo Bon, G Cazzolato
Basic Life Sciences|January 1, 1988
Isolation and partial characterization of an oxidized LDL in humansP Avogaro, G Bittolo Bon, G Cazzolato
Artery|January 1, 1983
Changes of apolipoprotein B molecular weight and immunoreactivity in malondialdehyde-modified low density lipoproteinsG Bittolo Bon, G Cazzolato, P Avogaro
Journal of Lipid Research|August 1, 1981
Preparative isotachophoresis of human plasma high density lipoproteins HDL2 and HDL3G Bittilo Bon, G Cazzolato, P Avogaro
Acta Diabetologica Latina|October 1, 1984
Lipids, lipoproteins and apolipoproteins in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitusG Bittolo Bon, G Cazzolato, P Avogaro
Atherosclerosis|November 1, 1991
Some questions concerning a small, more electronegative LDL circulating in human plasmaP Avogaro, G Cazzolato, G Bittolo-Bon
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Pharmacological Research|May 1, 1994
Probucol protects low-density lipoproteins from in vitro and in vivo oxidationG Bittolo-Bon, G Cazzolato, P Avogaro
Arteriosclerosis (Dallas, Tex.)|January 1, 1985
Apoprotein B-48 is a constant finding in very low density lipoproteins of humansG Cazzolato, G Bittolo Bon, P Avogaro
Atherosclerosis|February 1, 1988
A question concerning apo B-48P Avogaro, G Cazzolato, G Bittolo Bon
Arteriosclerosis (Dallas, Tex.)|January 1, 1988
Presence of a modified low density lipoprotein in humansP Avogaro, G B Bon, G Cazzolato
Advances in Experimental Medicine and Biology|January 1, 1987
Meaning of a modified LDL in humansP Avogaro, G Bittolo Bon, G Cazzolato
Basic Life Sciences|January 1, 1988
Isolation and partial characterization of an oxidized LDL in humansP Avogaro, G Bittolo Bon, G Cazzolato
Artery|January 1, 1983
Changes of apolipoprotein B molecular weight and immunoreactivity in malondialdehyde-modified low density lipoproteinsG Bittolo Bon, G Cazzolato, P Avogaro
Journal of Lipid Research|August 1, 1981
Preparative isotachophoresis of human plasma high density lipoproteins HDL2 and HDL3G Bittilo Bon, G Cazzolato, P Avogaro
Acta Diabetologica Latina|October 1, 1984
Lipids, lipoproteins and apolipoproteins in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitusG Bittolo Bon, G Cazzolato, P Avogaro
Atherosclerosis|November 1, 1991
Some questions concerning a small, more electronegative LDL circulating in human plasmaP Avogaro, G Cazzolato, G Bittolo-Bon
Pageof 8